Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.

Yang, Kaiyuan; Man, Weitao; Jing, Linkai; Sun, Zhenxing; Liang, Ping; Wang, James; Wang, Guihuai

Yang, Kaiyuan; Man, Weitao; Jing, Linkai; Sun, Zhenxing; Liang, Ping; Wang, James; Wang, Guihuai.

Afiliação

Yang K; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Man W; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Jing L; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Sun Z; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Liang P; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Wang J; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Wang G; School of Clinical Medicine, Tsinghua University, Beijing, China; Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address: guihuai_wang@163.com.

World Neurosurg ; 143: e157-e165, 2020 11.

Article em En | MEDLINE | ID: mdl-32688042

Assuntos

Antineoplásicos Alquilantes/uso terapêutico; Antineoplásicos Imunológicos/uso terapêutico; Quimiorradioterapia Adjuvante; Quimioterapia Adjuvante; Glioblastoma/terapia; Procedimentos Neurocirúrgicos; Neoplasias da Medula Espinal/terapia; Adolescente; Adulto; Fatores Etários; Idoso; Bevacizumab/uso terapêutico; Criança; Feminino; Glioblastoma/diagnóstico por imagem; Glioblastoma/metabolismo; Glioblastoma/patologia; Humanos; Isocitrato Desidrogenase/metabolismo; Avaliação de Estado de Karnofsky; Antígeno Ki-67/metabolismo; Imageamento por Ressonância Magnética; Masculino; Pessoa de Meia-Idade; Prognóstico; Intervalo Livre de Progressão; Estudos Retrospectivos; Neoplasias da Medula Espinal/diagnóstico por imagem; Neoplasias da Medula Espinal/metabolismo; Neoplasias da Medula Espinal/patologia; Temozolomida/uso terapêutico; Fatores de Tempo; Proteína Supressora de Tumor p53/genética; Proteína Supressora de Tumor p53/metabolismo; Adulto Jovem

Palavras-chave

Chemotherapy; Primary spinal cord glioblastoma; Prognosis; Radiotherapy; Surgery

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Medula Espinal / Quimioterapia Adjuvante / Glioblastoma / Antineoplásicos Alquilantes / Procedimentos Neurocirúrgicos / Quimiorradioterapia Adjuvante / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: World Neurosurg Assunto da revista: NEUROCIRURGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google